Veracyte | VCYT - Zinsaufwendungen Für Schuld

Aktienkurs
31.84
Täglich Wechseln
-0.94 -2.87%
Monatlich
-10.94%
Jährlich
0.06%
Q1 Prognose
30.88




Zinsaufwendungen Für Schuld Veränderung Datum
Agenus USD 16.02M 2.85M 2025-12
Agilent USD 25M 2M 2025-12
Anika Therapeutics 189.44M 1.76M 2025-09
Arrowhead Research USD 22.5M 811K 2025-12
Bruker USD 20M 4.3M 2025-09
Exact Sciences USD 9.79M 46K 2025-09
Heron Therapeutics USD 600K 100K 2024-12
Illumina USD 25M 0 2025-09
Intrexon USD 2K 5K 2024-06
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
Laboratory Of America USD 55M 1000K 2025-12
Ligand Pharmaceuticals USD 910K 243K 2025-09
Myriad Genetics USD 4.4M 600K 2025-12
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Siemens EUR 435M 1000K 2025-12
Sonic Healthcare AUD 86.91M 43.94M 2024-12
Thermo Fisher Scientific USD 365M 18M 2025-12
Veracyte USD 2K 1000 2023-12
Waters USD 8.62M 18.02M 2025-12